Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of depression in patients with Parkinson's disease

Trial Profile

Treatment of depression in patients with Parkinson's disease

Phase of Trial: Phase II

Latest Information Update: 26 Nov 2015

At a glance

  • Drugs Nortriptyline (Primary) ; Paroxetine (Primary)
  • Indications Depression; Dysthymic disorder; Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2011 Results published in the American Journal of Geriatric Psychiatry.
    • 08 Apr 2009 Change in protocol patients with psychosis and heart block as exclusion criteria added as reported by ClinicalTrials.gov.
    • 08 Apr 2009 GlaxoSmithKline reported as trial sponsor by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top